Theravance Biopharma R&D IP, LLC
US Patent
| Assay Description The assays were performed in 384-well white opaque plates at 37° C. using the fluorogenic peptide substrates at a concentration of 10 μM in Assa... |
US Patent US10759813 (2020)
BindingDB Entry DOI: 10.7270/Q2XW4NW0 |